Cargando…

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators

This in-vivo human bioassay can be used to study human volunteers and patients. Samples are collected from pertinent tissue sites such as the skin via aseptically inserted microdialysis catheters (Dermal Dialysis, Erlangen, Germany). Illustrated in this example is the collection of interstitial flui...

Descripción completa

Detalles Bibliográficos
Autores principales: Angst, Martin S, Tingle, Martha, Schmelz, Martin, Carvalho, Brendan, Yeomans, David C
Formato: Texto
Lenguaje:English
Publicado: MyJove Corporation 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762925/
https://www.ncbi.nlm.nih.gov/pubmed/19229167
http://dx.doi.org/10.3791/1074
_version_ 1782172962908012544
author Angst, Martin S
Tingle, Martha
Schmelz, Martin
Carvalho, Brendan
Yeomans, David C
author_facet Angst, Martin S
Tingle, Martha
Schmelz, Martin
Carvalho, Brendan
Yeomans, David C
author_sort Angst, Martin S
collection PubMed
description This in-vivo human bioassay can be used to study human volunteers and patients. Samples are collected from pertinent tissue sites such as the skin via aseptically inserted microdialysis catheters (Dermal Dialysis, Erlangen, Germany). Illustrated in this example is the collection of interstitial fluid from experimentally inflamed skin in human volunteers. Sample collection can be combined with other experimental tests. For example, the simultaneous assessment of locally released biochemicals and subjective sensitivity to painful stimuli in experimentally inflamed skin provides the critical biochemical-behavioral link to identify biomarkers of pain and inflammation. Presented assay in the living human organism allows for mechanistic insight into tissue-specific processes underlying pain and/or inflammation. The method is also well suited to examine the effectiveness of existing or novel interventions - such as new drug candidates - targeting the treatment of painful and/or inflammatory conditions. This article will provide a detailed description on the use of microdialysis techniques for collecting interstitial fluid from experimentally inflamed skin lesion of human study subjects. Interstitial fluid samples are typically processed with aid of multiplex bead array immunoassays allowing assaying up to 100 analytes in samples as small in volume as 50 microliters.
format Text
id pubmed-2762925
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher MyJove Corporation
record_format MEDLINE/PubMed
spelling pubmed-27629252011-03-14 Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators Angst, Martin S Tingle, Martha Schmelz, Martin Carvalho, Brendan Yeomans, David C J Vis Exp Medicine This in-vivo human bioassay can be used to study human volunteers and patients. Samples are collected from pertinent tissue sites such as the skin via aseptically inserted microdialysis catheters (Dermal Dialysis, Erlangen, Germany). Illustrated in this example is the collection of interstitial fluid from experimentally inflamed skin in human volunteers. Sample collection can be combined with other experimental tests. For example, the simultaneous assessment of locally released biochemicals and subjective sensitivity to painful stimuli in experimentally inflamed skin provides the critical biochemical-behavioral link to identify biomarkers of pain and inflammation. Presented assay in the living human organism allows for mechanistic insight into tissue-specific processes underlying pain and/or inflammation. The method is also well suited to examine the effectiveness of existing or novel interventions - such as new drug candidates - targeting the treatment of painful and/or inflammatory conditions. This article will provide a detailed description on the use of microdialysis techniques for collecting interstitial fluid from experimentally inflamed skin lesion of human study subjects. Interstitial fluid samples are typically processed with aid of multiplex bead array immunoassays allowing assaying up to 100 analytes in samples as small in volume as 50 microliters. MyJove Corporation 2008-12-01 /pmc/articles/PMC2762925/ /pubmed/19229167 http://dx.doi.org/10.3791/1074 Text en Copyright © 2008, Journal of Visualized Experiments http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Medicine
Angst, Martin S
Tingle, Martha
Schmelz, Martin
Carvalho, Brendan
Yeomans, David C
Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
title Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
title_full Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
title_fullStr Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
title_full_unstemmed Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
title_short Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
title_sort human in-vivo bioassay for the tissue-specific measurement of nociceptive and inflammatory mediators
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762925/
https://www.ncbi.nlm.nih.gov/pubmed/19229167
http://dx.doi.org/10.3791/1074
work_keys_str_mv AT angstmartins humaninvivobioassayforthetissuespecificmeasurementofnociceptiveandinflammatorymediators
AT tinglemartha humaninvivobioassayforthetissuespecificmeasurementofnociceptiveandinflammatorymediators
AT schmelzmartin humaninvivobioassayforthetissuespecificmeasurementofnociceptiveandinflammatorymediators
AT carvalhobrendan humaninvivobioassayforthetissuespecificmeasurementofnociceptiveandinflammatorymediators
AT yeomansdavidc humaninvivobioassayforthetissuespecificmeasurementofnociceptiveandinflammatorymediators